No Data
Earnings Preview: 2seventy Bio to Report Financial Results Pre-market on November 12
$2seventy bio(TSVT.US)$ is scheduled to release its financial results pre-market on November 12 ET. Earnings PreviewAnalysts estimate $2seventy bio(TSVT.US)$ to post revenue of USD14.54M for 2024Q3,
Analysts Are Bullish on These Healthcare Stocks: Arvinas Holding Company (ARVN), 2seventy Bio (TSVT)
2seventy Bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference
Bristol-Myers Raises Outlook Ahead of Consensus After Q3 Beat
Express News | 2Seventy Bio- Co, Bristol Myers Squibb Share Equally in All Profits, Losses Related to Development, Manufacture, Commercialization of Abecma in U.s
Express News | 2Seventy Bio - Abecma (Idecabtagene Vicleucel, or Ide-Cel) Generated About $77 Mln in U.S. Revenue During Q3 2024
No Data
No Data